Holen Sie sich die Stockscreener-App
4.88
5.24%
-0.27
Handel nachbörslich:
4.90
0.02
+0.41%
Finanzdaten der Diamedica Therapeutics Inc-Aktie (DMAC)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Research and Development |
0.03%
3.676
|
3.677 | 3.272 | 2.543 | 3.618 |
| Operating Income/Loss |
1.83%
-5.741
|
-5.848 | -5.157 | -4.741 | -5.521 |
| Income/Loss From Continuing Operations Before Tax |
0.10%
-5.144
|
-5.139 | -4.464 | -4.47 | -5.265 |
| Income Tax Expense/Benefit |
68.18%
0.007
|
0.022 | 0.007 | 0.007 | 0.007 |
| Income/Loss From Continuing Operations After Tax |
0.19%
-5.151
|
-5.161 | -4.471 | -4.477 | -5.272 |
Net Income/Loss
|
0.19%
-5.151
|
-5.161 | -4.471 | -4.477 | -5.272 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
1,991%
37.96
|
1.8154 | 37.95 | 27.31 | 26.45 |
| Basic Earnings Per Share |
0.00%
-0.14
|
-0.14 | -0.12 | -0.16 | -0.20 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
3.32%
1.57%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):